Developer docs
API playgroundTry for free, no card

Search company profiles

Parry Nutraceuticals

Full company profile

uuid000zonv

Namestring
Parry Nutraceuticals
Legal namestring
E.I.D.- Parry (India) Limited
Company typeenum
Private
Founded yearint
1977
Descriptiontext

Parry Nutraceuticals is a division of E.I.D.- Parry (India) Limited, itself part of the $9.3B Murugappa Group, specializing in the large-scale cultivation and processing of microalgae-based ingredients and finished nutraceutical products. Founded on research initiated by the Murugappa Chettiar Research Centre in 1977 and commencing commercial production in 1996, the company operates two manufacturing facilities in Tamil Nadu, India (Oonaiyur and Saveriapuram) and holds the distinction of being the first and only USP ingredient-verified Spirulina producer globally (since 2004). Its core technology platform centers on open-pond cultivation with full-spectrum sunlight exposure, the proprietary Tuymai Process for continuous automated filtration, and PS 2.0 downstream processing designed to preserve cell integrity and nutrient density. Product claims include 30% higher phycocyanin/carotenoid levels versus prior cultivation methods and heavy metal levels 70% below EU Organic norms.

The company operates a dual B2B/B2C revenue model. The B2B ingredients business sells Organic Spirulina, Organic Chlorella, Phycocyanin, Natural Astaxanthin, and specialty ingredients (FlexPro MD, USPlus Saw Palmetto) to nutraceutical manufacturers, dietary supplement brands, and health food/beverage companies across 41+ countries. North American B2B sales are executed through Valensa, a wholly-owned subsidiary based in Florida that also develops functional cosmetic and pharmaceutical formulations. The B2C channel operates in India through the Parry Wellness brand, distributing Parry Organic Spirulina and Chlorella in powder and tablet formats via Amazon India. Community engagement and B2B lead generation are driven through the Algeek platform, which connects the company with manufacturers, distributors, and academicians. The company holds 8+ international certifications including USDA-NOP, Naturland, EU Organic, FDA GRAS, BRCGS, Non-GMO, India Organic, HALAL, and Star-K Kosher, supporting premium positioning in regulated markets.

Pricing is quote-based for B2B ingredients (distributed via direct enterprise sales and Algeek community) and unit-based for B2C products on Amazon India. Revenue, specific pricing, and division-level headcount are not publicly disclosed. The company has delivered an estimated 1.5 billion doses cumulatively and benefits from parent-group operational scale, capital access, and ESG positioning via initiatives such as Project NANNEER (4.5 billion liters of water under management) and a solar plant covering ~25% of daytime energy consumption.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microalgae cultivation, nutraceutical ingredients, dietary supplements, spirulina manufacturing, functional food ingredients
Industry4 codes
1Herbal & Botanical Supplements
CodeCRADAGADPrimaryYes
2Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)
CodeCRADAGAIPrimaryNo
3Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol)
CodeAFAJAKAIPrimaryNo
4Prebiotics & Dietary Fibers (Inulin, FOS/GOS, Resistant Starch, Beta-Glucan, Psyllium)
CodeAFAJAKAFPrimaryNo
NAICS code1 code
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Food And Kindred Products2000
Product category
Nutraceutical Ingredients
Social media profiles1 record
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Ingredients and Supplements
TypeOne Time License
Description

Large-scale production and sale of microalgae-based solutions (Organic Spirulina, Organic Chlorella, Phycocyanin, Natural Astaxanthin) as ingredients and dietary supplements to nutraceutical, dietary supplement, health foods, and beverages industries globally.

parrynutraceuticals.com
2Branded Consumer Products
TypeTransaction Fee
Description

Direct-to-consumer sales of Parry Organic Spirulina and Chlorella products (powder and tablets) in India through Amazon India marketplace.

parrynutraceuticals.com
3Specialty Ingredients
TypeOne Time License
Description

Sale of specialty ingredients including FlexPro MD (joint health), USPlus Saw Palmetto (prostate health) through Valensa brand for North American market.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
Pricing details1 tier
1Consumer products sold individually on Amazon India
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products available: Parry Organic Spirulina Powder and Tablets, Parry Organic Chlorella Powder and Tablets. Specific prices not listed on company website.

parrynutraceuticals.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Parry Wellness
Description

The consumer products branch of Parry Nutraceuticals that develops super foods for maintenance of good health.

parrynutraceuticals.com
+4 more records
Core offering1 text field

Parry Nutraceuticals produces microalgae-based nutritional solutions including Organic Spirulina, Organic Chlorella, Phycocyanin, and Natural Astaxanthin for global nutraceutical, dietary supplement, health food, and beverage manufacturers. Through its Valensa US subsidiary it offers branded specialty ingredients (FlexPro MD joint health formula and USPlus Saw Palmetto). It also sells branded consumer products (Parry Organic Spirulina and Chlorella powders/tablets) through Parry Wellness and Amazon India in the domestic Indian market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 30% increased pigment levels (Carotenoids and Phycocyanin) compared to previous cultivation practices
+5 more records
Product overview1 text field

Parry Nutraceuticals, a division of EID Parry (part of Murugappa Group), produces microalgae-based nutritional supplements and ingredients for nutraceuticals, dietary supplements, health foods, and beverages. The core product portfolio centers on Organic Spirulina (tablets, powder, granules, and XTRA high-phycocyanin variant) and Organic Chlorella (tablets and powder), supplemented by combination products (Spirulina+Chlorella, Spirulina+Astaxanthin), Organic Super Greens blends, and specialty ingredients like phycocyanin powder. Through its Valensa US subsidiary, the company also commercializes FlexPro MD® (joint health) and USPlus® Saw Palmetto (prostate health) formulations. Products are sold B2B to manufacturers and distributors globally, and B2C in India via Amazon India and the Parry Wellness online store.

Product and service8 records
1Organic Spirulina
CategoryMicroalgae Ingredient
Description

USDA-NOP, Naturland, and EU-certified organic spirulina in tablets, powder, and granules formats. The first and only USP ingredient-verified spirulina globally, produced using open-pond cultivation with full-spectrum sunlight. Available in standard format and XTRA variant with high phycocyanin content (above 20%). Rich in carotenoids, phycocyanin, sulphated polysaccharides, essential amino acids, and GLA fatty acid. Sold B2B as an ingredient to nutraceutical, dietary supplement, health food, and beverage manufacturers globally.

2Organic Chlorella
CategoryMicroalgae Ingredient
Description

Organic chlorella with cracked-open cells for high bioavailability of nutrients. Contains 350-400 mcg/100g of active Vitamin B12. Available in tablets and powder formats. Features high chlorophyll content for detox properties, growth factor for tissue repair, carotenoids (beta carotene and lutein), and iron with better bioavailability than synthetic sources.

3Organic Spirulina and Chlorella Combination Tablets
CategoryCombination Dietary Supplement
Description

A combination supplement of spirulina and chlorella in tablet format, providing both energy and detox benefits in one product. Supports everyday cellular homeostasis and acts as an effective detoxifier.

4Organic Spirulina and Natural Astaxanthin Tablets
CategoryCombination Dietary Supplement
Description

Tablet combining spirulina with natural astaxanthin for neurological function, eye health, and joint health support. Offered in Spiruzan Green and Spiruzan Blue variants.

5Organic Super Greens
CategoryCombination Dietary Supplement
Description

Alkalizing blend of spirulina, chlorella, barley grass, and wheat grass in powder and tablet formats. Rich in dietary fibre, promotes natural digestion, and supports everyday detoxification.

6Organic Phycocyanin Powder
CategoryMicroalgae Ingredient
Description

Phycocyanin powder derived from organic spirulina, a natural antioxidant providing energy and everyday protection against immunogens and pathogens. Available in organic and natural variants.

7FlexPro MD
CategoryJoint Health Supplement
Description

Patented joint health formula from Valensa (Parry's US subsidiary), clinically proven to provide relief for joint aches and pains. Available as joint formula with Omega-3 Softgel.

8USPlus Saw Palmetto
CategoryProstate Health Supplement
Description

The only USP-verified saw palmetto extract from Valensa, providing science-backed quality and monograph compliance. Available as USPlus Saw Palmetto Extract USP, 45% Powdered Extract, and USPlus Saw Palmetto with Pumpkin Seed Vegetarian Softgel for prostate health.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Valensa, based in Florida USA, is a wholly-aligned subsidiary and key business unit of Parry Nutraceuticals, serving as the North American hub for botanically sourced nutraceuticals. It creates science-based formulations for nutraceuticals supplements, functional foods, general nutrition, functional cosmetic ingredients, and pharmaceutical formulations. Valensa develops and markets exclusive products including FlexPro MD and USPlus Saw Palmetto.

2Parry Wellness
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Parry Wellness is the consumer products branch of Parry Nutraceuticals that develops superfoods for maintenance of good health. It manages B2C sales in India including Amazon India distribution for Parry Organic Spirulina and Chlorella products.

parrynutraceuticals.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

AMM Foundation is the philanthropic arm of Murugappa Group that supports Parry's community water resource management initiative, Project NANNEER. The foundation has helped rejuvenate over 20 water bodies in South India covering 800+ acres, with 4.5 billion liters of water under management.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Siruthuli is a Coimbatore-based Non-Governmental Organization that partners with EID Parry on Project NANNEER for community water resource management and water body rejuvenation in South India.

5Algeek Community Members
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

The Algeek community connects Parry with manufacturers, distributors, and academicians globally. Members receive recipe support, technical support on products, and can request free product samples. The community facilitates B2B relationships and partnerships in the microalgae nutraceuticals industry.

parrynutraceuticals.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large US-based supplement manufacturer and brand that may purchase Parry-type microalgae ingredients and sells competing spirulina and chlorella products. Represents a customer-competitor overlap given Parry's B2B ingredient model.

TypeBroad incumbent
Description

Japan-based diversified chemicals company that owns Earthrise Nutritionals. Operates in microalgae ingredients through its subsidiary and competes with Parry in the broader B2B spirulina market. Significantly larger enterprise with broader portfolio across pigments, chemicals, and life sciences.

TypeRegional player
Description

Portugal-based microalgae producer (part of the Greentech group) focused on European markets. Produces organic spirulina and chlorella ingredients under EU Organic certification, competing with Parry in European B2B channels.

TypeBroad incumbent
Description

Algae-based ingredient company that developed fermentation-based microalgae products for food, nutrition, and personal care. Represents a different cultivation model (heterotrophic fermentation) competing indirectly with Parry's open-pond microalgae ingredients.

TypeEmerging player
Description

China-based one of the world's largest spirulina producers with significant production capacity. Competes with Parry primarily on cost in the bulk ingredient market, though typically lacks Parry's premium certification stack.

TypeBroad incumbent
Description

Dutch multinational producing ingredients including algae-based products for food, nutrition, and personal care. Competes with Parry in microalgae-based nutraceutical ingredients and food applications; broader portfolio spans food preservation, baking, and biochemicals.

TypeDirect peer
Description

US-based large-scale spirulina producer acquired by DIC Corporation (Japan). Directly competes with Parry in the bulk organic spirulina ingredients market, targeting nutraceutical and food manufacturers globally. Both companies emphasize organic certification and bulk B2B supply.

TypeDirect peer
Description

Hawaii-based spirulina and astaxanthin brand owned by Cyanotech. Directly competes with Parry's spirulina and astaxanthin consumer products, particularly in the North American health-conscious consumer market.

TypeDirect peer
Description

Hawaii-based producer of microalgae-based products including BioAstin (natural astaxanthin) and Spirulina Pacifica. Directly competes with Parry's astaxanthin and spirulina offerings, with vertically integrated cultivation and processing similar to Parry's model.

TypeBroad incumbent
Description

US-based manufacturer and supplier of nutraceutical, cosmeceutical, and food ingredients with patented botanical extracts. Comparable to Parry's Valensa subsidiary in offering branded, certified, science-backed botanical ingredients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance13 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Parry Nutraceuticals

Nutraceutical Ingredientsparrynutraceuticals.com

What Parry Nutraceuticals does

Parry Nutraceuticals is a division of E.I.D.- Parry (India) Limited, itself part of the $9.3B Murugappa Group, specializing in the large-scale cultivation and processing of microalgae-based ingredients and finished nutraceutical products. Founded on research initiated by the Murugappa Chettiar Research Centre in 1977 and commencing commercial production in 1996, the company operates two manufacturing facilities in Tamil Nadu, India (Oonaiyur and Saveriapuram) and holds the distinction of being the first and only USP ingredient-verified Spirulina producer globally (since 2004). Its core technology platform centers on open-pond cultivation with full-spectrum sunlight exposure, the proprietary Tuymai Process for continuous automated filtration, and PS 2.0 downstream processing designed to preserve cell integrity and nutrient density. Product claims include 30% higher phycocyanin/carotenoid levels versus prior cultivation methods and heavy metal levels 70% below EU Organic norms.

The company operates a dual B2B/B2C revenue model. The B2B ingredients business sells Organic Spirulina, Organic Chlorella, Phycocyanin, Natural Astaxanthin, and specialty ingredients (FlexPro MD, USPlus Saw Palmetto) to nutraceutical manufacturers, dietary supplement brands, and health food/beverage companies across 41+ countries. North American B2B sales are executed through Valensa, a wholly-owned subsidiary based in Florida that also develops functional cosmetic and pharmaceutical formulations. The B2C channel operates in India through the Parry Wellness brand, distributing Parry Organic Spirulina and Chlorella in powder and tablet formats via Amazon India. Community engagement and B2B lead generation are driven through the Algeek platform, which connects the company with manufacturers, distributors, and academicians. The company holds 8+ international certifications including USDA-NOP, Naturland, EU Organic, FDA GRAS, BRCGS, Non-GMO, India Organic, HALAL, and Star-K Kosher, supporting premium positioning in regulated markets.

Pricing is quote-based for B2B ingredients (distributed via direct enterprise sales and Algeek community) and unit-based for B2C products on Amazon India. Revenue, specific pricing, and division-level headcount are not publicly disclosed. The company has delivered an estimated 1.5 billion doses cumulatively and benefits from parent-group operational scale, capital access, and ESG positioning via initiatives such as Project NANNEER (4.5 billion liters of water under management) and a solar plant covering ~25% of daytime energy consumption.

Parry Nutraceuticals firmographics

Firmographics
Name
Parry Nutraceuticals
Legal name
E.I.D.- Parry (India) Limited
Website
https://parrynutraceuticals.com
Company type
Private
Founded year
1977
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Parry Nutraceuticals industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Food (Health) Supplement Retailers (456191)
SIC
Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
akta.pro primary industry
Herbal & Botanical Supplements (CRADAGAD)
akta.pro secondary industries
Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI), Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol) (AFAJAKAI), Prebiotics & Dietary Fibers (Inulin, FOS/GOS, Resistant Starch, Beta-Glucan, Psyllium) (AFAJAKAF)

Keywords

  • Microalgae cultivation
  • Nutraceutical ingredients
  • Dietary supplements
  • Spirulina manufacturing
  • Functional food ingredients

Where Parry Nutraceuticals is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices4 records

Markets served

Parry Nutraceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

  1. B2B Ingredients and Supplements: Large-scale production and sale of microalgae-based solutions (Organic Spirulina, Organic Chlorella, Phycocyanin, Natural Astaxanthin) as ingredients and dietary supplements to nutraceutical, dietary supplement, health foods, and beverages industries globally.
  2. Branded Consumer Products: Direct-to-consumer sales of Parry Organic Spirulina and Chlorella products (powder and tablets) in India through Amazon India marketplace.
  3. Specialty Ingredients: Sale of specialty ingredients including FlexPro MD (joint health), USPlus Saw Palmetto (prostate health) through Valensa brand for North American market.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goConsumer products sold individually on Amazon India

Go-to-market motion4 records

Distribution channels4 records

Marketing channels5 records

Parry Nutraceuticals product offering

Product offering

Core offering

Parry Nutraceuticals produces microalgae-based nutritional solutions including Organic Spirulina, Organic Chlorella, Phycocyanin, and Natural Astaxanthin for global nutraceutical, dietary supplement, health food, and beverage manufacturers. Through its Valensa US subsidiary it offers branded specialty ingredients (FlexPro MD joint health formula and USPlus Saw Palmetto). It also sells branded consumer products (Parry Organic Spirulina and Chlorella powders/tablets) through Parry Wellness and Amazon India in the domestic Indian market.

Product overview

Parry Nutraceuticals, a division of EID Parry (part of Murugappa Group), produces microalgae-based nutritional supplements and ingredients for nutraceuticals, dietary supplements, health foods, and beverages. The core product portfolio centers on Organic Spirulina (tablets, powder, granules, and XTRA high-phycocyanin variant) and Organic Chlorella (tablets and powder), supplemented by combination products (Spirulina+Chlorella, Spirulina+Astaxanthin), Organic Super Greens blends, and specialty ingredients like phycocyanin powder. Through its Valensa US subsidiary, the company also commercializes FlexPro MD® (joint health) and USPlus® Saw Palmetto (prostate health) formulations. Products are sold B2B to manufacturers and distributors globally, and B2C in India via Amazon India and the Parry Wellness online store.

Differentiator

Problem solved

Functional benefit

Brands

  • Parry Wellness: The consumer products branch of Parry Nutraceuticals that develops super foods for maintenance of good health.
  • Valensa
  • USPlus
  • FlexPro MD
  • Algeek

Products and services

  • Organic Spirulina USDA-NOP, Naturland, and EU-certified organic spirulina in tablets, powder, and granules formats. The first and only USP ingredient-verified spirulina globally, produced using open-pond cultivation with full-spectrum sunlight. Available in standard format and XTRA variant with high phycocyanin content (above 20%). Rich in carotenoids, phycocyanin, sulphated polysaccharides, essential amino acids, and GLA fatty acid. Sold B2B as an ingredient to nutraceutical, dietary supplement, health food, and beverage manufacturers globally.
  • Organic Chlorella Organic chlorella with cracked-open cells for high bioavailability of nutrients. Contains 350-400 mcg/100g of active Vitamin B12. Available in tablets and powder formats. Features high chlorophyll content for detox properties, growth factor for tissue repair, carotenoids (beta carotene and lutein), and iron with better bioavailability than synthetic sources.
  • Organic Spirulina and Chlorella Combination Tablets A combination supplement of spirulina and chlorella in tablet format, providing both energy and detox benefits in one product. Supports everyday cellular homeostasis and acts as an effective detoxifier.
  • Organic Spirulina and Natural Astaxanthin Tablets Tablet combining spirulina with natural astaxanthin for neurological function, eye health, and joint health support. Offered in Spiruzan Green and Spiruzan Blue variants.
  • Organic Super Greens Alkalizing blend of spirulina, chlorella, barley grass, and wheat grass in powder and tablet formats. Rich in dietary fibre, promotes natural digestion, and supports everyday detoxification.
  • Organic Phycocyanin Powder Phycocyanin powder derived from organic spirulina, a natural antioxidant providing energy and everyday protection against immunogens and pathogens. Available in organic and natural variants.
  • FlexPro MD Patented joint health formula from Valensa (Parry's US subsidiary), clinically proven to provide relief for joint aches and pains. Available as joint formula with Omega-3 Softgel.
  • USPlus Saw Palmetto The only USP-verified saw palmetto extract from Valensa, providing science-backed quality and monograph compliance. Available as USPlus Saw Palmetto Extract USP, 45% Powdered Extract, and USPlus Saw Palmetto with Pumpkin Seed Vegetarian Softgel for prostate health.

Quantifiable outcome

  • 30% increased pigment levels (Carotenoids and Phycocyanin) compared to previous cultivation practices
  • +5 more outcomes

Companies that use Parry Nutraceuticals

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Parry Nutraceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Parry Nutraceuticals partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, strategic and minor.

  • ValensacoreStrategic or Co-development PartnerValensa, based in Florida USA, is a wholly-aligned subsidiary and key business unit of Parry Nutraceuticals, serving as the North American hub for botanically sourced nutraceuticals. It creates science-based formulations for nutraceuticals supplements, functional foods, general nutrition, functional cosmetic ingredients, and pharmaceutical formulations. Valensa develops and markets exclusive products including FlexPro MD and USPlus Saw Palmetto.
  • Parry WellnesscoreStrategic or Co-development PartnerParry Wellness is the consumer products branch of Parry Nutraceuticals that develops superfoods for maintenance of good health. It manages B2C sales in India including Amazon India distribution for Parry Organic Spirulina and Chlorella products.
  • AMM FoundationstrategicStrategic or Co-development PartnerAMM Foundation is the philanthropic arm of Murugappa Group that supports Parry's community water resource management initiative, Project NANNEER. The foundation has helped rejuvenate over 20 water bodies in South India covering 800+ acres, with 4.5 billion liters of water under management.
  • SiruthuliminorStrategic or Co-development PartnerSiruthuli is a Coimbatore-based Non-Governmental Organization that partners with EID Parry on Project NANNEER for community water resource management and water body rejuvenation in South India.
  • Algeek Community MemberscoreChannel Partner/ Reseller/ DistributorThe Algeek community connects Parry with manufacturers, distributors, and academicians globally. Members receive recipe support, technical support on products, and can request free product samples. The community facilitates B2B relationships and partnerships in the microalgae nutraceuticals industry.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Parry Nutraceuticals competitors and assessment

Company assessment

Broad incumbents

  • NOW Foods: Large US-based supplement manufacturer and brand that may purchase Parry-type microalgae ingredients and sells competing spirulina and chlorella products. Represents a customer-competitor overlap given Parry's B2B ingredient model.
  • DIC Corporation: Japan-based diversified chemicals company that owns Earthrise Nutritionals. Operates in microalgae ingredients through its subsidiary and competes with Parry in the broader B2B spirulina market. Significantly larger enterprise with broader portfolio across pigments, chemicals, and life sciences.
  • TerraVia Holdings (formerly Solazyme): Algae-based ingredient company that developed fermentation-based microalgae products for food, nutrition, and personal care. Represents a different cultivation model (heterotrophic fermentation) competing indirectly with Parry's open-pond microalgae ingredients.
  • Corbion: Dutch multinational producing ingredients including algae-based products for food, nutrition, and personal care. Competes with Parry in microalgae-based nutraceutical ingredients and food applications; broader portfolio spans food preservation, baking, and biochemicals.
  • Sabinsa Corporation: US-based manufacturer and supplier of nutraceutical, cosmeceutical, and food ingredients with patented botanical extracts. Comparable to Parry's Valensa subsidiary in offering branded, certified, science-backed botanical ingredients.

Regional players

  • Allmicroalgae: Portugal-based microalgae producer (part of the Greentech group) focused on European markets. Produces organic spirulina and chlorella ingredients under EU Organic certification, competing with Parry in European B2B channels.

Emerging players

  • Zhejiang Binmei Biotechnology: China-based one of the world's largest spirulina producers with significant production capacity. Competes with Parry primarily on cost in the bulk ingredient market, though typically lacks Parry's premium certification stack.

Direct peers

  • Earthrise Nutritionals: US-based large-scale spirulina producer acquired by DIC Corporation (Japan). Directly competes with Parry in the bulk organic spirulina ingredients market, targeting nutraceutical and food manufacturers globally. Both companies emphasize organic certification and bulk B2B supply.
  • Nutrex Hawaii: Hawaii-based spirulina and astaxanthin brand owned by Cyanotech. Directly competes with Parry's spirulina and astaxanthin consumer products, particularly in the North American health-conscious consumer market.
  • Cyanotech Corporation: Hawaii-based producer of microalgae-based products including BioAstin (natural astaxanthin) and Spirulina Pacifica. Directly competes with Parry's astaxanthin and spirulina offerings, with vertically integrated cultivation and processing similar to Parry's model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Parry Nutraceuticals social profiles

Digital presence

Parry Nutraceuticals compliance and trust

Trust signal

Compliance13 records

Parry Nutraceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Parry Nutraceuticals leadership team

Management profile

Number of profiles

Parry Nutraceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Parry Nutraceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Parry Nutraceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parry Nutraceuticals

What does Parry Nutraceuticals do?

Parry Nutraceuticals produces microalgae-based nutritional solutions including Organic Spirulina, Organic Chlorella, Phycocyanin, and Natural Astaxanthin for global nutraceutical, dietary supplement, health food, and beverage manufacturers. Through its Valensa US subsidiary it offers branded specialty ingredients (FlexPro MD joint health formula and USPlus Saw Palmetto). It also sells branded consumer products (Parry Organic Spirulina and Chlorella powders/tablets) through Parry Wellness and Amazon India in the domestic Indian market.

Is Parry Nutraceuticals a public or private company?

Parry Nutraceuticals is a private company. It is classified as public and is currently operating.

When was Parry Nutraceuticals founded?

Parry Nutraceuticals was founded in 1977. It employs 1,001 to 5,000 people.

Where is Parry Nutraceuticals based?

Parry Nutraceuticals is headquartered in Chennai, India, in the Asia region.

How does Parry Nutraceuticals make money?

Three revenue lines are on record. B2B Ingredients and Supplements are the primary driver. The others are branded Consumer Products and specialty Ingredients.

Who are Parry Nutraceuticals's main competitors?

Broad incumbents on record are NOW Foods, DIC Corporation, TerraVia Holdings (formerly Solazyme), Corbion and Sabinsa Corporation. Allmicroalgae is listed as a regional player. Zhejiang Binmei Biotechnology is listed as an emerging player. Direct peers are Earthrise Nutritionals, Nutrex Hawaii and Cyanotech Corporation.

Does Parry Nutraceuticals have an API?

No public API is recorded for Parry Nutraceuticals.

What industry is Parry Nutraceuticals in?

Parry Nutraceuticals's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots). Its NAICS code is 456191 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Market Research FutureAlgae Protein Market Size, Share, Trends, Forecast by 2035The algae protein market was valued at USD 218.70 million in 2025 and is projected to grow to USD 449.52 million by 2035, registering a CAGR of 7.82%, driven by regulatory approvals including the US FDA's endorsement of Galdieria extract blue in June 2025 and Europe's approval of over 20 algae species under the Novel Food Regulation. Key market players profiled include DIC Corporation, Cyanotech Corporation, Parry Nutraceuticals, Corbion N.V., Roquette Frères, Earthrise Nutritionals, Allmicroalgae, Brevel, Phycom, and Far East Bio-Tec Co., with the competitive landscape exhibiting medium concentration where the top five players hold an estimated 35–45% of global revenue.PR NewswireSpirulina Extract Market | 6.0% CAGR | Asia Pacific, USA, Europe Lead | DIC Corp, Cyanotech, Parry Nutraceuticals Drive Clean-Label RevolutionFuture Market Insights published a market analysis projecting the global spirulina extract market will grow from USD 530 million in 2026 to USD 948 million by 2036, representing a 6.0% CAGR. The report identifies clean-label transitions from synthetic dyes to natural phycocyanin, rising plant-based protein demand, and advances in microencapsulation technology as primary growth drivers, with powdered spirulina extract and nutraceutical applications leading current market segments. Asia Pacific, led by India and China, is forecast to be the fastest-growing region, while key players including DIC Corporation, Cyanotech Corporation, and Parry Nutraceuticals are positioned to benefit from supply chain advantages and high-purity product development.PR NewswireGlobal Spirulina Market to Reach US$ 1,287.13 Million by 2032, Driven by Nutraceutical Demand, Sustainable Protein Adoption & Functional Food GrowthThe global spirulina market is projected to grow from USD 683.15 million in 2025 to USD 1,287.13 million by 2032, expanding at a CAGR of 9.47%, driven by rising demand for plant-based protein, nutraceuticals, and functional foods. Asia-Pacific accounts for over 40% of global production, with China and India serving as the primary supply hubs, while North America leads premium demand for organic and phycocyanin-enriched products. Key market players including Cyanotech Corporation, DIC Corporation, Parry Nutraceuticals, and Algatech Ltd. are expanding through smart farming, organic certifications, and high-value ingredient extraction.PR NewswirePursuit of New Protein Sources for Feed and Food Industry Enriches the Value Chain in Single Cell Protein (SCP) Market, Valuation to Climb at CAGR of 9.3% During 2020 - 2030: TMRA Transparency Market Research report projects the ASEAN single cell protein (SCP) market to expand at a CAGR of 9.3% during 2020–2030, reaching a valuation of US$ 232 billion by 2030-end, driven by rising demand for animal-derived protein expected to reach 1,250 million tonnes annually by 2050. The report identifies key industry participants including Calysta, Inc., Novus International, Inc., Parry Nutraceuticals Limited, Unibio A/S, Alltech, Inc., and Evonik Industries AG as companies expanding their stakes in the SCP market, with biotech firms ramping up investments in sourcing SCP from fungi, bacteria, and algae for food and feed applications. Spirulina is highlighted as a key area of innovation due to its health benefits including hypoglycemic, antihypertensive, and hypolipidemic properties.PR NewswireGlobal Phycocyanin Market 2021 Production Value Forecasts and AnalysisReportsnReports published a market research report titled 'Global Phycocyanin Market 2021 Production Value Forecasts and Analysis,' which covers industry definitions, manufacturing technologies, and regional forecasts from 2011 to 2021. The study analyzes key global manufacturers including Dainippon Ink and Chemicals, Parry Nutraceuticals, EcoFuel Laboratories, Japan Algae, Norland Biotech, and Fuqing King Dnarmsa Spirulina.